Skip to main content
EJNMMI Research
Fig. 3 | EJNMMI Research

Fig. 3

From: Multimodal image-guided surgery of HER2-positive breast cancer using [111In]In-DTPA-trastuzumab-IRDye800CW in an orthotopic breast tumor model

Fig. 3

Biodistribution of 30 μg [111In]In-DTPA-trastuzumab-IRDye800CW 48 h after injection in orthotopic MCF7 tumor-bearing mice (black and white blocks), compared with uptake in BT474 tumors (blue). Tumor uptake in MCF7 tumors was significantly lower in comparison with uptake in BT474 tumors. Values represent mean ± SD. *Tumor uptake p < 0.0001

Back to article page